In vivo study of bleeding and antithrombotic effects of low molecular weight heparin ML-009723
Malinowska, K.; Iqbal, O.; Hoppensteadt, D.A.; Walenga, J.M.; Fareed, J.
Seminars in Thrombosis and Hemostasis 19(Suppl 1): 58-62
1993
ISSN/ISBN: 0094-6176 PMID: 8395732 Document Number: 415923
Document emailed within 1 workday
Related Documents
Kaiser, B.; Hauptmann, J.; Markwardt, F. 1988: Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative Folia Haematologica 115(1-2): 119-125Tapparelli, C.; Metternich, R.; Gfeller, P.; Gafner, B.; Powling, M. 1995: Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin Thrombosis and Haemostasis 73(4): 641-647
Petralia, P.; Kakkar, A.K. 2004: Antithrombotic therapy with low molecular weight heparin in cancer patients European Journal of Medical Research 9(3): 119-124
Doutremepuich, C.; Bonini, F.; de Seze, O.; Toulemonde, F.; Bayrou, B. 1986: Neutralization of a very low molecular weight heparin fraction CY 222 by protamine. in vitro and in vivo study Therapie 41(6): 433-436
Lai, S.; Barbano, B.; Cianci, R.; Gigante, A.; Di Donato, D.; Asllanaj, B.; Dimko, M.; Mariotti, A.; Morabito, S.; Pugliese, F. 2010: The risk of bleeding associated with low molecular weight heparin in patients with renal failure Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 27(6): 649-654
Warning, A.; Nies, D.; Wolf, H.; Welzel, D. 1987: Effect of low molecular weight heparin on coagulation parameters and bleeding time in healthy volunteers Arzneimittel-Forschung 37(7): 847-849
Barrowcliffe, T.W.; Thomas, D.P. 1988: Low molecular weight heparins: antithrombotic and haemorrhagic effects and standardization Acta Chirurgica Scandinavica. Supplementum 543: 57-64
Uzan, A.; Marin, J.; Mardiguian, J.; Trillou, M.; Kiosseff, T.; Rougeot, C. 1987: Comparative pharmacokinetic study, in the dog, of low molecular weight heparin and standard heparin by labelling with 35S Annales Pharmaceutiques Francaises 45(6): 429-437
Harenberg, J.; Stehle, G.; Dempfle, C.E.; von Hodenberg, E.; Heene, D.L. 1989: The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects Folia Haematologica 116(6): 967-980
Ryan, K.E.; Lane, D.A.; Flynn, A.; Shepperd, J.; Ireland, H.A.; Curtis, J.R. 1991: Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis Thrombosis and Haemostasis 66(3): 277-282
Velut, J.G.; Boubli, L.; Lheureux, G.; d'Ercole, C.; Harlé, J.R.; Bagnères, D.; Frances, Y. 2001: Low-molecular-weight heparin prophylaxis during pregnancy: a retrospective study in 119 women Presse Medicale 30(13): 635
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Párama, J.A.; Llorens, R.; Sáenz de Buruaga, J.; Rocha, E. 1994: Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass Medicina Clinica 102(16): 637-638
Huisse, M.G.; Huet, Y.; Zygelman, M.; Guillin, M.C. 1983: Thrombopenia induced by standard heparin. Therapeutic attempt using a low molecular weight heparin Presse Medicale 12(10): 643
Bannon, P.G.; Kim, M.J.; Dean, R.T.; Dawes, J. 1995: Augmentation of vascular endothelial barrier function by heparin and low molecular weight heparin Thrombosis and Haemostasis 73(4): 706-712
Eriksson, E.; Wollter, I.M.; Christenson, B.; Stigendal, L.; Risberg, B. 1988: Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin Thrombosis and Haemostasis 59(2): 284-288
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Bârzu, T.; Molho, P.; Tobelem, G.; Petitou, M.; Caen, J.P. 1984: Binding of heparin and low molecular weight heparin fragments to human vascular endothelial cells in culture Nouvelle Revue Francaise d'Hematologie 26(4): 243-247
Morita, Y.; Makino, H.; Ota, K.; Wada, J.; Shikata, K.; Kashihara, N.; Ikeda, S.; Ogura, T.; Ota, Z. 1994: Effect of heparin and low-molecular-weight heparin on proliferative glomerulonephritis Nihon Jinzo Gakkai Shi 36(7): 832-838
Chigot, P.; De Gennes, C.; Samama, M.M. 1996: Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin Journal des Maladies Vasculaires 21(3): 121-125